Cadila Healthcare informs about press release

03 Feb 2020 Evaluate

Cadila Healthcare has informed that the company has enclosed a copy of press release dated February 3, 2020 titled ‘Zydus receives approval from DCGI for Saroglitazar Magnesium for treatment of Type II Diabetes.’ The contents of the press release give full details.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

931.45 -3.75 (-0.40%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×